Holen Sie sich die Stockscreener-App
27.53
1.82%
-0.51
Handel nachbörslich:
27.53
Schlusskurs vom Vortag:
$28.04
Offen:
$27.72
24-Stunden-Volumen:
249.33K
Relative Volume:
1.29
Marktkapitalisierung:
$1.80B
Einnahmen:
$1.21B
Nettoeinkommen (Verlust:
$570.23M
KGV:
3.18
EPS:
8.6571
Netto-Cashflow:
$-293.03M
1W Leistung:
+1.96%
1M Leistung:
-6.58%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$27.47
$27.80
1-Wochen-Bereich:
$26.76
$28.89
52-Wochen-Spanne:
$25.68
$30.91
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Firmenname
Lakefront Biotherapeutics Nv Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare LKFT vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
27.53 | 1.83B | 1.21B | 570.23M | -293.03M | 8.6571 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lakefront Biotherapeutics Nv Adr Aktie (LKFT) Neueste Nachrichten
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR) - The Globe and Mail
Grifols, S.A. (GRFS) stock price, news, quote and history - Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB) - The Globe and Mail
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
Lakefront Biotherapeutics director resigns for Sanofi role By Investing.com - Investing.com Nigeria
Lakefront Biotherapeutics director resigns for Sanofi role - Investing.com
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com Nigeria
Galapagos Q1 2026 presentation: Ouro deal, rebranding highlight transformation - Investing.com
LKFTLakefront Biotherapeutics NV ADR Latest SEC Filings - Finviz
GXEA Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com South Africa
Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com
Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated - Bez Kabli
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
Lakefront Receives Transparency Notification from Bank of America - Yahoo Finance Australia
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
LKFT Stock Price and Chart — EURONEXT:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Invesco NASDAQ Future Gen 200 ETF Holdings - Quiver Quantitative
Genmab A/S (GMAB) stock price, news, quote and history - Yahoo Finance UK
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Finanzdaten der Lakefront Biotherapeutics Nv Adr-Aktie (LKFT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):